BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 19336547)

  • 21. Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk.
    Hsu WL; Yu KJ; Chien YC; Chiang CJ; Cheng YJ; Chen JY; Liu MY; Chou SP; You SL; Hsu MM; Lou PJ; Wang CP; Hong JH; Leu YS; Tsai MH; Su MC; Tsai ST; Chao WY; Ger LP; Chen PR; Yang CS; Hildesheim A; Diehl SR; Chen CJ
    Am J Epidemiol; 2011 Feb; 173(3):292-9. PubMed ID: 21148719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.
    Hjalgrim H; Ekström-Smedby K; Rostgaard K; Amini RM; Molin D; Hamilton-Dutoit S; Schöllkopf C; Chang ET; Ralfkiaer E; Adami HO; Glimelius B; Melbye M
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1561-6. PubMed ID: 17684129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for nasopharyngeal carcinoma.
    Lin TM; Chang HJ; Chen CJ; Cheng YJ; Yang CS; Tu SM; Ito Y; Kawamura A; Hirayama T
    Anticancer Res; 1986; 6(4):791-6. PubMed ID: 3752958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres.
    Chen Y; Xu Y; Zhao W; Xiao X; Zhou X; Lin L; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
    BMC Cancer; 2018 Feb; 18(1):190. PubMed ID: 29444646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.
    Yu KJ; Hsu WL; Pfeiffer RM; Chiang CJ; Wang CP; Lou PJ; Cheng YJ; Gravitt P; Diehl SR; Goldstein AM; Chen CJ; Hildesheim A
    Clin Cancer Res; 2011 Apr; 17(7):1906-14. PubMed ID: 21447725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
    Guo ZM; Liu WW; He JH
    Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
    Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The purification and application of Epstein-Barr virus gp125].
    Wang G; Pi G; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
    Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Change and effect of Epstein Barr virus (EBV) antigen induced T8 cells in nasopharyngeal carcinoma patients and EBV seropositive individuals].
    Huang PC
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):12-6. PubMed ID: 8392927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Screening of dominant epitopes of antigens related to antibodies in the sera of patients with nasopharyngeal carcinoma].
    Zhang Y; Xiao XB; Zhang CQ; Li JL; Sun Y; Ye YZ; Feng KT
    Ai Zheng; 2004 Sep; 23(9):999-1004. PubMed ID: 15363190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
    Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
    Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of immunity to Epstein-Barr virus in Malaysian children.
    Yadav MS; Malliga N; Ablashi DV
    Microbiologica; 1987 Jan; 10(1):29-35. PubMed ID: 3033449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies.
    Chen Y; Yao K; Sun H; Qing J; Peng GY
    Chin Med J (Engl); 2005 May; 118(9):725-30. PubMed ID: 15899133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.